Home > Inhibitors & Agonists > Others

Others

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC1697 Dc-k2in212 Novel potent CDK2 inhibitor with selectivities above 10-fold over CDK1/4/6/7/9/12 above 10-fold, displaying anti-proliferative activity against A2058 melanoma and MV4-11 leukemia cell lines and low toxicity on human normal cell lines, inhibiting CDK2-medi
DCC1698 Dcn1-ubc12 Inhibitor Dn-2 Novel potent and selective DCN1-UBC12 inhibitor for anticardiac fibrotic effects, specifically targetinbg DCN1 at molecular and cellular levels, effectively reversing angiotensin (Ang) II-induced cardiac fibroblast activation
DCC1699 Dc-prc2in-01 Novel PRC2 Inhibitor, Targeting EZH2-EED Interaction
DCC1700 Dc-s100 Novel, Selective Histone Methyltransferase SET7 Inhibitor
DCC1701 Dc-s238 Novel, Potent and Selective Histone Methyltransferase SET7 Inhibitor
DCC1702 Dc-s239 Novel, Potent and Selective Histone Methyltransferase SET7 Inhibitor
DCC1703 Dc-teadin02 Novel potent and selective TEAD autopalmitoylation inhibitor, inhibiting TEADs transcription activity and downstream gene expression
DCC1704 Dcz3112 Novel Hsp90 inhibitor, exerts potent antitumor activity against HER2-positive breast cancer through disruption of Hsp90-Cdc37 interaction
DCC1705 Dd-04-015 Novel selective BTK degrader, demonstrating prolonged pharmacodynamic effects
DCC1706 Dd04107 Featured Novel inhibitor of α-calcitonin gene-related peptide (α-CGRP) exocytotic release from primary sensory neurons, selectively interacting with Synaptotagmin 1
DCC1707 Ddc4002 First-generation allosteric EGFR inhibitor, binding to the allosteric site of EGFR along with ATP that leads to inhibition of cell proliferation and arrest of EGFR L858R/T790M/C797S signalling
DCC1708 Ddd00015314 Novel activator of the GUS reporter activity, specific increasing in stumpy reporter gene expression
DCC1709 Ddd01035881 Novel transmission blocker of antimalarials, targeting male gametes
DCC1710 Ddd-028 Potent potential non-opioid, non-cannabinoid analgesic for neuropathic and inflammatory pain
DCC1711 Ddd100097 Potent inhibitor of Trypanosoma brucei N-myristoyltransferase (TbNMT) with markedly improved blood-brain barrier permeability
DCC1712 Ddhctp Sodium Salt Novel potent and broad-spectrum antiviral agent, acting as a chain terminator for viral RNA polymerase
DCC1713 Ddo-2117 Novel potent blocker of mixed lineage leukemia 1 (MLL1)-WDR5 interaction, inhibiting MLL1 complex H3K4 methyltransferase activity
DCC1714 Ddo-2213 Novel Potent and Orally Bioavailable Inhibitor of the WDR5-Mixed Lineage Leukemia 1 (MLL1) Protein-Protein Interaction for the Treatment of MLL Fusion Leukemia
DCC1715 Ddo-7132 Novel NQO1 substrate, inhibiting cancer cell (NQO1-rich A549 cell line) growth
DCC1716 Ddo-7204 Novel Nrf2 activator
DCC1717 ddpm-1457 Potent mGAT4 inhibitor
DCC1718 Ddr1-in-2 Potent and selective DDR1 receptor tyrosine kinase inhibitor
DCC1719 Ddri-18 Inhibitor of nonhomologous end-joining (NHEJ) DNA repair following double strand DNA breaks induced by ionizing radiation, enhancing the effects of DNA-damaging cancer drugs like etoposide, camptothecin and doxorubicin
DCC1720 Ddr-trk-1n Negative control for DDR-TRK-1
DCC1721 Dea Nonoate Sodium Salt NO donor, generating a controlled release of nitric oxide in solution.
DCC1722 Deacm-caged D-luciferin Coumarin-caged D-luciferin, being excited in the caged group only by light of wavelength ranging within 400-430 nm
DCC1723 Deac-pda-atp Fluorophore to myosin or actomyosin
DCC1724 Debio-1452-nh3 Novel potent inhibitor of the enoyl-acyl carrier protein reductase FabI, reducing bacterial burden in mice and rescuing mice from lethal infections with clinical isolates of Acinetobacter baumannii, Klebsiella pneumoniae and E. coli
DCC1725 Deferasirox Ferrate(iii) Tripotassium Complex Deferasirox iron complex
DCC1726 Deferoxamine Hydrochloride Iron chelating agent, chelating iron from intra-lysosomal ferritin and hemosiderin forming ferrioxamine, a water-soluble chelate excreted by the kidneys and in the feces via the bile

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X